眾康可維2019冠狀病毒病疫苗 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "眾康可維2019冠狀病毒病疫苗" in Chinese language version.

refsWebsite

Global rank Chinese rank

13web.archive.org

1^st place

3worldcat.org

5^th place

12^th place

2jamanetwork.com

2,650^th place

1,976^th place

2nih.gov

4^th place

5^th place

2doi.org

2^nd place

23^rd place

2hk01.com

379^th place

11^th place

2nytimes.com

7^th place

31^st place

1cnstock.com

low place

1,045^th place

1sina.cn

2,037^th place

80^th place

1cyberctm.com

low place

1,284^th place

1cayetano.edu.pe

low place

1channelnewsasia.com

1,127^th place

683^rd place

1yahoo.com

38^th place

9^th place

1nmpa.gov.cn

low place

6,139^th place

1wenweipo.com

2,249^th place

74^th place

1who.int

195^th place

179^th place

1mb.com.ph

1,231^st place

2,005^th place

1zj.gov.cn

low place

1,732^nd place

cayetano.edu.pe

COMUNICADO A LA OPINIÓN PÚBLICA. Universidad Peruana Cayetano Heredia. March 9, 2021 [2021-06-17]. （原始内容存档于2021-11-07）.

channelnewsasia.com

Sinopharm's Wuhan affiliate boosts COVID-19 shot annual capacity to 1 billion doses. CNA. [2021-06-08]. （原始内容存档于2021-06-08）（英语）.

cnstock.com

news.cnstock.com

杨晓明被罢免！曾带队研发国内首款新冠灭活疫苗. 天津日报. 2024-04-27 [2024-04-28]. （原始内容存档于2024-05-01）.

cyberctm.com

國藥武漢生物所新冠疫苗保護率7成2. 澳門廣播電視股份有限公司. 2021-02-24 [2022-01-30]. （原始内容存档于2022-01-30）.

doi.org

Xia, Shengli; Duan, Kai; Zhang, Yuntao; Zhao, Dongyang; Zhang, Huajun; Xie, Zhiqiang; Li, Xinguo; Peng, Cheng; Zhang, Yanbo; Zhang, Wei; Yang, Yunkai. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials. JAMA. 2020-09-08, 324 (10): 951-960. ISSN 0098-7484. PMC 7426884 . PMID 32789505. doi:10.1001/jama.2020.15543 （英语）.
Al Kaabi, Nawal; Zhang, Yuntao; Xia, Shengli; Yang, Yunkai; Al Qahtani, Manaf M.; Abdulrazzaq, Najiba; Al Nusair, Majed; Hassany, Mohamed; Jawad, Jaleela S.; Abdalla, Jehad; Hussein, Salah Eldin. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial. JAMA. 2021-07-06, 326 (1). ISSN 0098-7484. PMC 8156175 . PMID 34037666. doi:10.1001/jama.2021.8565 （英语）.

hk01.com

新冠肺炎｜國藥集團第二款滅活疫苗正式上市　料年產量達1億劑次. 香港01. 2021-02-28 [2021-06-17]. （原始内容存档于2021-08-04）.
新冠疫苗︱秘魯媒體指有效率僅1到3成　國藥：報道嚴重失實. 香港01. 2021-03-11 [2021-06-17]. （原始内容存档于2021-08-06）.

jamanetwork.com

Xia, Shengli; Duan, Kai; Zhang, Yuntao; Zhao, Dongyang; Zhang, Huajun; Xie, Zhiqiang; Li, Xinguo; Peng, Cheng; Zhang, Yanbo; Zhang, Wei; Yang, Yunkai. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials. JAMA. 2020-09-08, 324 (10): 951-960. ISSN 0098-7484. PMC 7426884 . PMID 32789505. doi:10.1001/jama.2020.15543 （英语）.
Al Kaabi, Nawal; Zhang, Yuntao; Xia, Shengli; Yang, Yunkai; Al Qahtani, Manaf M.; Abdulrazzaq, Najiba; Al Nusair, Majed; Hassany, Mohamed; Jawad, Jaleela S.; Abdalla, Jehad; Hussein, Salah Eldin. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial. JAMA. 2021-07-06, 326 (1). ISSN 0098-7484. PMC 8156175 . PMID 34037666. doi:10.1001/jama.2021.8565 （英语）.

mb.com.ph

De Vera, Analou. FDA grants EUA to COVID-19 vaccine Sinopharm manufactured by Wuhan affiliate. Manila Bulletin. August 25, 2021 [2021-10-19]. （原始内容存档于2021-10-06）.

nih.gov

ncbi.nlm.nih.gov

Xia, Shengli; Duan, Kai; Zhang, Yuntao; Zhao, Dongyang; Zhang, Huajun; Xie, Zhiqiang; Li, Xinguo; Peng, Cheng; Zhang, Yanbo; Zhang, Wei; Yang, Yunkai. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials. JAMA. 2020-09-08, 324 (10): 951-960. ISSN 0098-7484. PMC 7426884 . PMID 32789505. doi:10.1001/jama.2020.15543 （英语）.
Al Kaabi, Nawal; Zhang, Yuntao; Xia, Shengli; Yang, Yunkai; Al Qahtani, Manaf M.; Abdulrazzaq, Najiba; Al Nusair, Majed; Hassany, Mohamed; Jawad, Jaleela S.; Abdalla, Jehad; Hussein, Salah Eldin. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial. JAMA. 2021-07-06, 326 (1). ISSN 0098-7484. PMC 8156175 . PMID 34037666. doi:10.1001/jama.2021.8565 （英语）.

nmpa.gov.cn

国家药监局附条件批准国药中生武汉公司新型冠状病毒灭活疫苗（Vero细胞）注册申请. 国家药品监督管理局. 2021-02-25 [2021-02-25]. （原始内容存档于2021-03-02）.

nytimes.com

cn.nytimes.com

黄瑞黎. 中国批准国药集团新冠疫苗上市. 纽约时报. 2020-12-30 [2021-02-07]. （原始内容存档于2021-12-21）.

nytimes.com

Zimmer, Carl; Corum, Jonathan; Wee, Sui-Lee. Coronavirus Vaccine Tracker. The New York Times. [2021-03-30]. ISSN 0362-4331. （原始内容存档于2020-12-24）（美国英语）.

sina.cn

finance.sina.cn

我国又一新冠疫苗将进入临床试验，由武汉生物制品研究所有限责任公司研发，或为全球第三个. 金融界. 2020-04-13 [2021-06-17] –通过新浪财经.

web.archive.org

杨晓明被罢免！曾带队研发国内首款新冠灭活疫苗. 天津日报. 2024-04-27 [2024-04-28]. （原始内容存档于2024-05-01）.
國藥武漢生物所新冠疫苗保護率7成2. 澳門廣播電視股份有限公司. 2021-02-24 [2022-01-30]. （原始内容存档于2022-01-30）.
COMUNICADO A LA OPINIÓN PÚBLICA. Universidad Peruana Cayetano Heredia. March 9, 2021 [2021-06-17]. （原始内容存档于2021-11-07）.
Sinopharm's Wuhan affiliate boosts COVID-19 shot annual capacity to 1 billion doses. CNA. [2021-06-08]. （原始内容存档于2021-06-08）（英语）.
国家药监局附条件批准国药中生武汉公司新型冠状病毒灭活疫苗（Vero细胞）注册申请. 国家药品监督管理局. 2021-02-25 [2021-02-25]. （原始内容存档于2021-03-02）.
國藥武漢生物疫苗上市年產億劑. 文匯報. 2021-03-01 [2021-06-17]. （原始内容存档于2021-06-24）.
黄瑞黎. 中国批准国药集团新冠疫苗上市. 纽约时报. 2020-12-30 [2021-02-07]. （原始内容存档于2021-12-21）.
Zimmer, Carl; Corum, Jonathan; Wee, Sui-Lee. Coronavirus Vaccine Tracker. The New York Times. [2021-03-30]. ISSN 0362-4331. （原始内容存档于2020-12-24）（美国英语）.
"WHO Coronavirus (COVID-19) Dashboard". covid19.who.int. [2021-06-17]. （原始内容存档于2020-04-16）.
De Vera, Analou. FDA grants EUA to COVID-19 vaccine Sinopharm manufactured by Wuhan affiliate. Manila Bulletin. August 25, 2021 [2021-10-19]. （原始内容存档于2021-10-06）.
浙江省新冠肺炎疫情防控工作新闻发布会（第七十一场）. 浙江省人民政府门户网站. [2021-05-13]. （原始内容存档于2021-05-13）.
新冠肺炎｜國藥集團第二款滅活疫苗正式上市　料年產量達1億劑次. 香港01. 2021-02-28 [2021-06-17]. （原始内容存档于2021-08-04）.
新冠疫苗︱秘魯媒體指有效率僅1到3成　國藥：報道嚴重失實. 香港01. 2021-03-11 [2021-06-17]. （原始内容存档于2021-08-06）.

wenweipo.com

paper.wenweipo.com

國藥武漢生物疫苗上市年產億劑. 文匯報. 2021-03-01 [2021-06-17]. （原始内容存档于2021-06-24）.

who.int

covid19.who.int

"WHO Coronavirus (COVID-19) Dashboard". covid19.who.int. [2021-06-17]. （原始内容存档于2020-04-16）.

worldcat.org

Xia, Shengli; Duan, Kai; Zhang, Yuntao; Zhao, Dongyang; Zhang, Huajun; Xie, Zhiqiang; Li, Xinguo; Peng, Cheng; Zhang, Yanbo; Zhang, Wei; Yang, Yunkai. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials. JAMA. 2020-09-08, 324 (10): 951-960. ISSN 0098-7484. PMC 7426884 . PMID 32789505. doi:10.1001/jama.2020.15543 （英语）.
Al Kaabi, Nawal; Zhang, Yuntao; Xia, Shengli; Yang, Yunkai; Al Qahtani, Manaf M.; Abdulrazzaq, Najiba; Al Nusair, Majed; Hassany, Mohamed; Jawad, Jaleela S.; Abdalla, Jehad; Hussein, Salah Eldin. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial. JAMA. 2021-07-06, 326 (1). ISSN 0098-7484. PMC 8156175 . PMID 34037666. doi:10.1001/jama.2021.8565 （英语）.
Zimmer, Carl; Corum, Jonathan; Wee, Sui-Lee. Coronavirus Vaccine Tracker. The New York Times. [2021-03-30]. ISSN 0362-4331. （原始内容存档于2020-12-24）（美国英语）.

yahoo.com

tw.stock.yahoo.com

中國國藥武漢分支擴產疫苗年產能增至10億劑. 路透社中文新聞. 2021-06-01 [2021-06-17].

zj.gov.cn

浙江省新冠肺炎疫情防控工作新闻发布会（第七十一场）. 浙江省人民政府门户网站. [2021-05-13]. （原始内容存档于2021-05-13）.